28.17
-0.14%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Assure Tech (Hangzhou) Co
Its shares trade on Shanghai under the ticker 688075.SS. It has been listed since 18 November 2021. In the fiscal year to 31 December 2025, it reported net income of CN¥73.4m. At that date it held total assets of CN¥5.68bn and shareholders' equity of CN¥5.16bn.
Assure Tech (Hangzhou) Co., Ltd. engages in the research, development, production, and sale of point-of-care testing (POCT) reagents and instruments. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-11-18. The firm's products include antigen and antibody raw materials, immunochromatographic reagents and testing equipment, and dry biochemical reagents and testing equipment. The firm's POCT products cover eight areas of drug testing, infectious disease testing, chronic disease testing, pregnancy testing, tumor testing, myocardial testing, biochemical testing, and allergen testing. The firm's products are sold to the United States, Germany, Britain, Canada and other countries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 18 Nov 2021
- Employees
- 950
- Website
- diareagent.com ↗
Leadership
Pay as last reported
- Mr. Shisheng LingChairman of the Board, General Manager, since 2019CN¥6.6m
- Ms. Xueying JiangVice Chairman of the Board, Deputy General Manager, since 2019CN¥3.5m
- Ms. Min KangChief Financial OfficerCN¥118,800
- Mr. Wenkun DongDeputy General Manager, Director, since 2019CN¥3.0m
- Mr. Wentao WeiDeputy General ManagerCN¥2.2m
- Mr. Jun HanSecretary of the Board
- Mr. Yinqian HuangDirectorCN¥2.3m
- Mr. Weimin MaIndependent DirectorCN¥26,200
- Mr. Guobiao ZhangIndependent DirectorCN¥64,100
- Ms. Juanying ZhouIndependent DirectorCN¥64,100
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Assure Tech (Hangzhou) Co Ltd employs 950 full-time employees in Hangzhou, Zhejiang.
- The company's POCT products cover eight testing areas including infectious disease and chronic disease testing.
- Assure Tech's products are sold to the United States, Germany, and Britain, expanding international reach.
Weaknesses
- Assure Tech (Hangzhou) Co Ltd has a single headquarters city, Hangzhou, Zhejiang, limiting regional diversity.
- The company's IPO listing date is 18 November 2021, which may indicate limited market history.
- Assure Tech's business focuses on POCT reagents and instruments without mentioning broader product diversification.
Opportunities
- Assure Tech can expand into emerging markets like Canada and other countries with growing healthcare demand.
- The company's POCT products cover eight testing areas, offering potential for new market segments.
- Assure Tech's international sales to the United States, Germany, and Britain present opportunities for partnerships.
Threats
- Assure Tech (Hangzhou) Co Ltd faces competition in the Health Care sector from established global players.
- The company's reliance on POCT reagents and instruments may be vulnerable to technological shifts.
- Assure Tech's products are sold to specific countries, which could be affected by geopolitical tensions.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.